Association of prevalence of rhinitis, atopic eczema, rhinoconjunctivitis and wheezing with mortality from infectious diseases and with antibiotic susceptibility at a country level by Fsadni, Claudia et al.
Original Article
Asia Pacific
allergy
pISSN 2233-8276 · eISSN 2233-8268
Copyright © 2015. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. 
http://dx.doi.org/10.5415/apallergy.2015.5.3.145
Asia Pac Allergy 2015;5:145-155
http://apallergy.org
Association of prevalence of rhinitis, atopic 
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Background: It was previously reported that there is a positive correlation between incidence of type 1 diabetes and prevalence 
of asthma and atopic eczema. A negative correlation between the prevalence of type 1 diabetes and mortality from infectious 
diseases as well as a positive correlation with antibiotic susceptibility at a country level have also been reported.  
Objective: The aim of this study was to investigate the association between country prevalence of rhinitis, atopic eczema, 
rhinoconjunctivitis, and wheezing with mortality from infectious diseases and also with antibiotic susceptibility at a country level.  
Methods: Data for prevalence of rhinitis, eczema, rhinoconjunctivitis, and wheezing was obtained from the International Study of 
Asthma and Allergies in Childhood study (ISAAC). ISAAC Phase one was a multicentre multicountry cross sectional study involving 
over 700,000 children in 2 age groups of school children, 13–14 years old (adolescents) and 6–7 years old (children) in 156 centres 
from 56 countries. Mortality from infectious diseases was taken from World Health Organisation data. The Alexander project was 
used to identify antibiotic susceptibilities to common bacteria.
Results: There were significant positive correlations between atopic eczema and mortality from all infectious diseases studied, 
diarrhoeal illness, tropical infections, and childhood infections.  A negative correlation exists between the prevalence of rhinitis 
and Streptococcus pneumoniae susceptibility to penicillin and to erythromycin, rhinitis and Haemophilus influenzae susceptibility to 
ampicillin and between rhinoconjunctivitis and H. influenzae susceptibility to ampicillin.
Conclusion: Th1/Th2 responses might influence the pathogenesis of infectious disease mortality, while antibiotic overprescription 
could explain the negative association between atopy and antibiotic susceptibility.
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INTRODUCTION
Atopic eczema is a chronic inflammatory skin condition that 
appears to be potentially associated with genetic and acquired 
defects in the proteins and lipids in the outer layer of the 
epidermis. This leads to a breakdown in the barrier between the 
internal body structures and the environment. Eczema is often 
linked to other atopic conditions including asthma and allergic 
rhinitis and rhinoconjunctivitis [1]. It affects approximately 5% to 
20% of children worldwide [2] and the incidence appears to be on 
the increase. It appears to be higher in urban areas and developed 
countries, especially Western societies [3, 4].
Our group has previously reported a correlation between 
incidence of type 1 diabetes and prevalence of asthma and atopic 
eczema [5]. The ‘hygiene hypothesis’ proposes that lack of microbial 
exposure in early postnatal life predisposes to certain immune-
mediated diseases. It has been implicated in the pathogenesis of 
both type 1 diabetes [6] as well as in the pathogenesis of atopic 
diseases such as atopic eczema and asthma [7]. Lack of microbial 
exposure may therefore explain the observed correlation between 
the incidence of type 1 diabetes and prevalence of atopic disease. 
It has been suggested that infectious disease mortality and 
antibiotic susceptibility may be good markers of infective burden 
at a population level [8]. We therefore sought to investigate the 
possible relationship  between the country prevalence of rhinitis, 
atopic eczema, rhinoconjunctivitis, and wheezing as documented 
in the International Study of Asthma and Allergies in Childhood 
study (ISAAC) Phase one study [9] to mortality from infectious 
diseases as reported by the World Health Organization (WHO) 
[10, 11] and to antibiotic susceptibility data for Streptococcus 
pneumoniae and Haemiophilus influenzae as reported in the 
Alexander project [12].  It should be noted that the prevalence 
of type 1 diabetes has already been reported to be negatively 
correlated with mortality from infectious diseases and positively 
with antibiotic susceptibility at a country level [8].  
MATERIALS AND METHODS
The International Study of Asthma and Allergies in 
Childhood
The ISAAC involved three phases. Phase one being carried out 
between 1994 and 1995 with 156 collaborating centres in 56 
countries with a total of 721,601 children participating. This phase 
showed a variation in the prevalence of asthma symptoms in 
children aged 6–7 years and 13–14 years throughout the world 
with a predominance of atopic conditions in English-speaking 
countries [9]. Phase two was more focused on selected countries 
to investigate points of interest that arose from phase 1, whilst 
phase 3 was a repeat of phase 1 between 2000 and 2003.  For the 
purpose of our study, data from phase 1 in the 13- to 14-year age 
group was used.
WHO estimates of mortality and global burden of 
disease
The WHO estimates of mortality and burden of disease for 
member states for the year 2002 including country specific 
mortality and burden of disease for over 130 causes were 
reviewed.  These estimates are based on version 3 of the Global 
Burden of Disease study [10] as published in the World Health 
Report 2004 [11]. Available data include age-standardised death 
rates quoted per 100,000 population by cause and member state. 
Mortality data is grouped into (1) mortality from communicable, 
maternal, perinatal and nutritional conditions, (2) mortality from 
noncommunicable diseases, and (3) mortality from injuries. 
Within the mortality from communicable, maternal, perinatal, and 
nutritional conditions group, there are specific mortality rates from 
infectious and parasitic diseases in general as well as that from 
respiratory infection, tuberculosis and diarrhoeal diseases.
The Alexander project
The Alexander project [12] was established in 1992 and is an 
ongoing surveillance project that examines the susceptibility of 
bacteria responsible for adult community-acquired respiratory 
tract infections to a range of antibiotics. Between 1998 and 2002, 
isolates of Streptococcus pneumonia, Haemophilus influenza, and 
Moraxella catarrhalis were collected from centres in USA, Africa, 
Europe, the Far and Middle East, and Latin America and their 
susceptibility to 23 different antibiotics was tested.
Research design
Countries with data both in the ISAAC phase 1 study and in 
the WHO database were included in the study. For countries with 
multiple centre data, the mean country prevalence of rhinitis, 
atopic eczema, rhinoconjunctivitis, and wheezing was taken.
For countries which participated in the ISAAC study, the WHO 
country-specific age-standardised death rates (quoted per 
100,000 inhabitants) from infectious and parasitic diseases were 
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documented. These infections included respiratory infections, 
tuberculosis and diarrhoeal illness among others. We decided to 
choose mortality data related to common childhood infections to 
be able to look at the relationship between these infections and 
prevalence of common atopic symptoms at a population level for 
each country.
 The Alexander project was used to obtain data for antibiotic 
susceptibility. Country-specific antibiotic susceptibility data 
was available for 18 countries which participated in both the 
Alexander project (between 1998 and 2000) and the ISAAC 
phase I study. Country-specific antibiotic susceptibility data for S. 
pneumoniae and H. influenzae were available; these two organisms 
most commonly cause bacterial infections in childhood. We 
then proceeded to extract data for the four most important and 
commonly used antibiotics namely penicillin, erythromycin, 
doxycycline, and cotrimoxazole. Susceptibility of S. pneumoniae to 
penicillin and erythromycin was based on National Committee for 
Clinical Laboratory Standards breakpoints, while susceptibility of S. 
Pneumoniae to doxycycline and cotrimoxazole and susceptibility of 
H. influenzae to all antimicrobials were based on pharmacokinetic/
pharmacolodynamic breakpoints [12]
Data analysis
Prevalence of rhinitis, atopic eczema, rhinoconjunctivitis, and 
wheezing and mortality from communicable diseases
Pearson correlation analyses of the country-specific prevalence 
of rhinitis, atopic eczema, rhinoconjunctivitis, and wheezing to the 
country-specific mortality from all cause infectious and parasitic 
diseases, tuberculosis, diarrhoeal illnesses, tropical infections, 
childhood infections and from respiratory infections were 
performed.
Prevalence of rhinitis, atopic eczema, rhinoconjunctivitis, and 
wheezing and antibiotic susceptibility
Pearson correlation analyses were also carried out between 
the atopic symptoms mentioned above and the country-specific 
susceptibility of S. Pneumoniae and H. Influenzae to the antibiotics 
listed earlier.
RESULTS
Prevalence of rhinitis, atopic eczema, 
rhinoconjunctivitis, and wheezing and mortality from 
infectious diseases and respiratory infections
The country-specific prevalence of rhinitis, atopic eczema, 
rhinoconjunctivitis, and wheezing and mortality from infectious 
diseases, respiratory infections, tuberculosis, diarrhoeal illnesses, 
tropical infections, and childhood illnesses are shown in Table 
1. There was a significant positive correlation between atopic 
eczema and mortality from all infectious diseases studied (Fig. 1) (r 
= 0.33, p = 0.013), diarrhoeal illnesses (r = 0.33, p = 0.014), tropical 
infections (r = 0.39, p = 0.003), and childhood illnesses (r = 0.35, p 
= 0.008). There was no significant correlation between the above 
conditions and the mortality from respiratory infections when 
these were isolated from other infections (Table 2).
Prevalence of rhinitis, atopic eczema, 
rhinoconjunctivitis, and wheezing and antibiotic 
susceptibility
The correlation between prevalence of rhinitis, atopic eczema, 
rhinoconjunctivitis, and wheezing and antibiotic susceptibility are 
shown in Table 3.
There were significant negative correlations between rhinitis 
and S. pneumoniae susceptibility to penicillin (r = –0.51, p = 0.029) 
(Fig. 2) and erythromycin (r = –0.59, p = 0.010) (Fig. 3).  There were 
also significant negative correlations between rhinitis and H. 
influenzae susceptibility to ampicillin (r = –0.59, p = 0.010) (Fig. 4) 
and between rhinoconjunctivitis and H. influenzae susceptibility to 
ampicillin (r = –0.51, p = 0.030) (Fig. 5).
DISCUSSION
In our ecological study we found a significant positive 
correlation between the country prevalence of atopic eczema and 
the country’s mortality from infectious diseases. To our knowledge, 
this has not been previously reported. This relationship was true 
for total mortality from infectious diseases and parasitic infections 
(r = 0.33, p = 0.013) as well as to mortality from specific infections 
including diarrhoea (r = 0.33, p = 0.014), tropical infections (r = 
0.39, p = 0.030), and childhood infections (r = 0.35, p = 0.008). 
There was a similar trend for mortality from respiratory infections 
but this did not reach statistical significance. Our data suggest 
that there may be common genetic and/or environmental factors 
which predispose to both atopic eczema and to the risk and/or 
severity of infections. These may include factors which predispose 
to a predilection of a Th2 over a Th1 response, which has been 
reported to have a genetic element [13]. Th2/Th11 predominance 
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may lead to an increased risk of both atopic and infectious diseases. 
Atopic eczema is known to be associated with Th2 predominance 
[14, 15]. The relation between a Th2 response and increased risk 
of infections has been demonstrated in animal studies [16-18] as 
well as in humans [19, 20]. Another factor which may predispose 
to both atopic and infective conditions in later life could be lack of 
microbial exposure during early postnatal life, as suggested by the 
‘hygiene hypothesis’ [21]. This may be mediated through alteration 
of the gut microbiota, which may predispose to atopy [22, 23] as 
well as to infections [24]. 
Alternatively, atopy may itself lead to in Th2/Th1 predominance, 
which in turn may predispose to an increased infection risk. Atopic 
disease features increased systemic Th2 responses and Th2/Th1 
responses in lesional skin, but there is evidence that allergies also 
result in impaired innate immunity namely by Th2 polarisation 
[25]. Many mediator cells in atopy, including mast cells, basophils 
and eosinophils, are capable of shifting the balance to Th2 
polarization through production of interleukin-4 (IL-4) [26, 27]. IL-4 
is also thought to trigger fibronectin production by skin fibroblasts 
which facilitated bacterial attachment, the first step in establishing 
an infection [28]. Furthermore, Gros et al. [29] have reported that 
the enhanced Th2 immunity in patients with atopic dermatitis 
leads to an impairment of Th1 immune responses by altering the 
interferon-gamma responses of antigen presenting cells. One 
can speculate that the positive association between atopy and 
infectious disease mortality is based on the interaction between 
interleukins and type 1/2 cytokines. Hoffmann et al. [30] have 
shown that excessive types 1 and 2 cytokine responses secondary 
to interleukin regulatory processes in schistosomiasis increases 
mortality. Upregulation of the Th2 responses in atopic disease in 
the setting of interleukin deficiency could be one of the possible 
causes of increased mortality in these patients.
Respiratory infections have been reported to be more common 
and more severe in individuals with allergic diseases [31-33]. Our 
study, on the other hand, failed to show a correlation of allergic 
conditions with mortality from respiratory infections at country 
level, although there was a nonsignificant trend. This is probably 
Fig. 1. Correlation of prevalence of atopic eczema with infectious disease 
(ID) mortality.
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Table 2. Correlation analysis between ISAAC phase 1 and infectious disease 
mortality
Analysis by country & symptom Correlation (r) p value (two-sided)
Mortality from infectious diseases
Rhinitis –0.04 0.780
Atopic eczema 0.33 0.013*
Rhinoconjunctivitis 0.14 0.290
Wheezing –0.02 0.880
Mortality from respiratory infections
Rhinitis –0.01 0.930
Atopic eczema 0.23 0.080
Rhinoconjunctivitis 0.09 0.490
Wheezing –0.15 0.280
Mortality from TB
Rhinitis –0.25 0.063
Atopic eczema –0.13 0.340
Rhinoconjunctivitis –0.25 0.070
Wheezing –0.35 0.080
Mortality from diarrhoea
Rhinitis –0.06 0.910
Atopic eczema 0.33 0.014*
Rhinoconjunctivitis 0.26 0.056
Wheezing –0.15 0.270
Mortality from tropical infections
Rhinitis 0.12 0.380
Atopic eczema 0.39 0.003*
Rhinoconjunctivitis 0.21 0.120
Wheezing –0.07 0.620
Mortality from childhood infections
Rhinitis 0.03 0.820
Atopic eczema 0.35 0.008*
Rhinoconjunctivitis 0.27 0.950
Wheezing –0.17 0.220
ISAAC, International Study of Asthma and Allergies in Childhood study.
*p value of <0.05 was considered as statistically significant.
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due to the fact that such respiratory conditions are usually nonfatal 
and we studied mortality data rather than incidence of infections. 
It is therefore probable that total infectious disease mortality in a 
given country is a better marker of its total infective burden than is 
mortality from respiratory infections. We also found no association 
between mortality from tuberculosis and prevalence of atopic 
eczema. This may be due to the factors other than Th2/Th1 
predominance bein g more important in determining tuberculosis 
mortality, such as coinfection with human immunodeficiency 
virus.
In contrast to atopic eczema, we found no significant correlation 
between prevalence of wheezing, rhinoconjunctivitis and rhinitis 
and infectious disease mortality. This suggests that there are 
important differences between the pathophysiology of eczema 
and that of other allergic conditions. These may include the role of 
staphylococcal superantigen, which has been shown to facilitate 
epithelial presentation of allergen to Th2 cells [34] and the role of 
other infective agents in eczema [35].
We also explored the relationship between the same atopic 
conditions and antibiotic susceptibility of S. pneumoniae and 
H. influenzae. In our study we found a negative correlation 
between rhinitis and susceptibility of S. pneumoniae to penicillin 
and erythromycin and of H. influenzae to ampicillin. There was 
also a negative correlation between rhinoconjunctivitis and 
susceptibility of H. influenzae to ampicillin (Fig. 3). 
Antibiotic susceptibility is known to be inversely related with 
local use and abuse of antibiotics. Antibiotic susceptibility depends 
not only on personal use but also usage in the community as 
whole, including use in agriculture. It is therefore a strong marker of 
antibiotic exposure of the community. Our data therefore suggest 
that increased antibiotic use in a community may be associated 
with increased risk of atopic disease. Various mechanisms may be 
implicated. Firstly, increased antibiotic use may decrease bacterial 
exposure during early postnatal life. Bacterial exposure during 
these critical periods in early life may help in protecting against 
atopic disease by decreasing Th1 response [36]. Interestingly, 
Gram-positive bacteria seem to be more important in stimulating 
this response [37]. Antibiotic use can also cause long-lasting 
effects on the constitution and diversity of gut microbiota [38, 
39], which have been linked to increased risk of atopic disease 
[40-42]. Antibiotic use can also affect skin microbiota, which has 
been implicated in atopic eczema [43]. The proposed interactions 
between the various inflammatory pathways are summarised in 
Fig. 6.
Table 3. Correlation between ISAAC phase 1 and antibiotic sensitivity for 
Streptococcus pneumoniae and Haemophilus influenzae
Analysis by country & antibiotic 
sensitivity
Correlation 
(r)
p value 
(two-sided)
Atopic eczema
S. pneumoniae to penicillin –0.29 0.240
S. pneumoniae to erythromycin –0.38 0.110
S. pneumoniae to doxycycline –0.16 0.520
S. pneumoniae to cotrimoxazole –0.06 0.820
H. influenzae to ampicillin 0.17 0.780
H. influenzae to erythromycin
H. influenzae to doxycycline 0.15 0.390
H. influenzae to cotrimoxazole –0.39 0.500
Rhinitis
S. pneumoniae to Penicillin –0.51 0.029*
S. pneumoniae to erythromycin –0.51 0.027*
S. pneumoniae to doxycycline –0.37 0.140
S. pneumoniae to cotrimoxazole –0.29 0.250
H. influenzae to ampicillin –0.59 0.010*
H. influenzae to erythromycin
H. influenzae to doxycycline –0.08 0.790
H. influenzae to cotrimoxazole 0.033 0.890
Rhinoconcjunctivitis
S. pneumoniae to Penicillin –0.41 0.100
S. pneumoniae to erythromycin –0.34 0.180
S. pneumoniae to doxycycline –0.17 0.520
S. pneumoniae to cotrimoxazole –0.24 0.350
H. influenzae to ampicillin –0.51 0.030*
H. influenzae to erythromycin
H. influenzae to doxycycline 0.1 0.710
H. influenzae to cotrimoxazole –0.16 0.530
Wheezing
S. pneumoniae to Penicillin –0.16 0.530
S. pneumoniae to erythromycin 0.16 0.520
S. pneumoniae to doxycycline 0.35 0.150
S. pneumoniae to cotrimoxazole 0.03 0.910
H. influenzae to ampicillin –0.24 0.350
H. influenzae to erythromycin
H. influenzae to doxycycline –0.06 0.800
H. influenzae to cotrimoxazole –0.04 0.880
ISAAC, International Study of Asthma and Allergies in Childhood study.
*p value of <0.05 was considered as statistically significant.
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Strengths and limitations
This ecological study is based on international research projects 
involving large numbers of patients of the same age groups. 
Countries participating in all three studies were utilised for this 
analysis. The use of age standardized WHO mortality rates and 
the ISAAC 13- to 14-year-old cohort prevalence rates makes 
interpretation of results much more accurate and valid.
The main limitation of this study is that the data was obtained 
from three different research projects which were carried out at 
different times. However data from the ISAAC study shows there 
has very little change in prevalence of current wheeze, atopic 
eczema or rhinoconjunctivitis over time [44, 45]. Therefore, the 
time factor is unlikely to have had a major impact on our results. 
One important limitation of this ecological study is the presence 
of systematic differences that might have occurred during disease 
Fig. 2. Correlation of prevalence of rhinitis with Penicillin susceptibility of 
Streptococcus pneumoniae. Fig. 5. Correlation of prevalence of rhinoconcjunctivitis with ampicillin 
susceptibility of Haemophilus influenzae.
Fig. 6. Posturated mechanistic interrelationships between infections and 
atopy.
Fig. 3. Correlation of prevalence of rhinitis with erythromycin susceptibil-
ity of Streptococcus pneumonia.
Fig. 4. Correlation of prevalence of rhinitis with ampicillin susceptibility of 
Haemophilus influenzae.
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classification, coding and diagnosis in different countries and 
centers. Another limitation is the potential confounding factors 
which might influence the distribution and diagnosis of disease in 
different geographical regions of the world.
The reliability of our findings depends on the reliability of 
the original data. However all the studies utilised very robust 
methodology. We also appreciate that we studied only organisms 
associated with respiratory infections and did not include 
Staphylococcus aureus which is an important skin pathogen 
associated with atopic eczema, but this data was not available
Conclusion
We found a significant positive correlation between the 
prevalence of atopic eczema and mortality from infectious diseases. 
A high prevalence of eczema could be a marker of environmental 
and/or genetic predisposition of the population to an enhanced 
Th2 response, which may lead to an increased infection risk (and 
hence higher mortality from infectious diseases). One possible 
environmental factor predisposing to a Th2/Th1 response could 
be lack of microbial exposure during critical periods in early 
postnatal life.
 We also found a negative correlation between rhinitis and 
susceptibility of S. pneumoniae to penicillin and erythromycin and 
of H. influenzae to ampicillin. The overprescription of antibiotics 
in these allergic conditions could have a direct effect on the 
susceptibilities of organisms to commonly used antimicrobials. 
More work is needed to confirm the role of interleukins in infectious 
disease mortality secondary to atopic disease. Furthermore an 
in-depth analysis is needed looking at the way antibiotics are 
prescribed for atopic disease both at a country level and at a 
global level.
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